Renal Clearable Luminescent Gold Nanoparticles: From the Bench to the Clinic.
Renal Clearable Luminescent Gold Nanoparticles: From the Bench to the Clinic.
复制标题
DOI:
10.1002/anie.201807847
复制
发表时间:
2019-03-22
期刊:
影响因子:
--
通讯作者:
Zheng J
中科院分区:
文献类型:
--
作者:
Yu M;Xu J;Zheng J
With more and more engineered nanoparticles (NPs) being translated to the clinic, the United States Food and Drug Administration (FDA) has recently issued the latest draft guidance on nanomaterial-containing drug products with an emphasis on understanding their in vivo transport and nano–bio interactions. Following these guidelines, NPs can be designed to target and treat diseases more efficiently than small molecules, have minimum accumulation in normal tissues, and induce minimum toxicity. In this Minireview, we integrate this guidance with our ten-year studies on developing renal clearable luminescent gold NPs. These gold NPs resist serum protein adsorption, escape liver uptake, target cancerous tissues, and report kidney dysfunction at early stages. At the same time, off-target gold NPs can be eliminated by the kidneys with minimum accumulation in the body. Additionally, we identify challenges to the translation of renal clearable gold NPs from the bench to the clinic.
登录
查看更多内容
影响因子:
10.8
作者:
Burns AA;Vider J;Ow H;Herz E;Penate-Medina O;Baumgart M;Larson SM;Wiesner U;Bradbury M
通讯作者:
Bradbury M
影响因子:
16.1
作者:
Aggarwal P;Hall JB;McLeland CB;Dobrovolskaia MA;McNeil SE
通讯作者:
McNeil SE
影响因子:
15.9
作者:
Benezra, Miriam;Penate-Medina, Oula;Bradbury, Michelle S.
通讯作者:
Bradbury, Michelle S.
影响因子:
15
作者:
Cheng K;Kothapalli SR;Liu H;Koh AL;Jokerst JV;Jiang H;Yang M;Li J;Levi J;Wu JC;Gambhir SS;Cheng Z
通讯作者:
Cheng Z
影响因子:
13.3
作者:
Chen, Jingyi;Glaus, Charles;Laforest, Richard;Zhang, Qiang;Yang, Miaoxian;Gidding, Michael;Welch, Michael J.;Xia, Younan
通讯作者:
Xia, Younan